Section Arrow
PLSE.NASDAQ
- Pulse Biosciences
Quotes are at least 15-min delayed:2026/08/25 15:35 EDT
Regular Hours
Last
 48.645
-0.485 (-0.99%)
Day High 
50.9 
Prev. Close
49.13 
1-M High
50.71 
Volume 
258.14K 
Bid
48.46
Ask
48.82
Day Low
47.65 
Open
49.73 
1-M Low
30.09 
Market Cap 
3.50B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 46.44 
20-SMA 42.01 
50-SMA 33.46 
52-W High 50.71 
52-W Low 12.56 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.17/-1.34
Enterprise Value
3.51B
Balance Sheet
Book Value Per Share
1.40
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
350.00K
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
LUCYInnovative Eyewear Inc.1.07-0.05-4.46%-- 
MDLNMedline Inc35.24+0.54+1.56%43.41PE
AVTRAvantor14.425+0.165+1.16%-- 
BAXBaxter International26.325-0.165-0.62%-- 
XRAYDENTSPLY SIRONA10.905+0.015+0.14%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.